Unité de Pathogénie Microbienne Moléculaire, Institut National de la Santé et de la Recherche Médicale (INSERM), U1202, Institut Pasteur, Paris, France.
Plate-forme de Génotypage des Eucaryotes, Pôle Biomics, Institut Pasteur, Paris, France.
mBio. 2019 Jul 16;10(4):e01315-19. doi: 10.1128/mBio.01315-19.
We have previously identified a crypt-specific core microbiota (CSCM) in the colons of healthy laboratory mice and related wild rodents. Here, we confirm that a CSCM also exists in the human colon and appears to be altered during colon cancer. The colonic microbiota is suggested to be involved in the development of colorectal cancer (CRC). Because the microbiota identified in fecal samples from CRC patients does not directly reflect the microbiota associated with tumor tissues themselves, we sought to characterize the bacterial communities from the crypts and associated adjacent mucosal surfaces of 58 patients (tumor and normal homologous tissue) and 9 controls with normal colonoscopy results. Here, we confirm that bacteria colonize human colonic crypts in both control and CRC tissues, and using laser-microdissected tissues and 16S rRNA gene sequencing, we further show that right and left crypt- and mucosa-associated bacterial communities are significantly different. In addition to and , and as with murine proximal colon crypts, environmental nonfermentative are found in human colonic crypts. and are more abundant in right-side tumors, whereas is more prevalent in left-side tumors. More precisely, is more abundant in crypts from cancerous samples in the right colon than in associated nontumoral samples from adjacent areas but not in left-side colonic samples. Future analysis of the interaction between these bacteria and the crypt epithelium, particularly intestinal stem cells, will allow deciphering of their possible oncogenic potential. Due to the huge number of bacteria constituting the human colon microbiota, alteration in the balance of its constitutive taxa (i.e., dysbiosis) is highly suspected of being involved in colorectal oncogenesis. Indeed, bacterial signatures in association with CRC have been described. These signatures may vary if bacteria are identified in feces or in association with tumor tissues. Here, we show that bacteria colonize human colonic crypts in tissues obtained from patients with CRC and with normal colonoscopy results. Aerobic nonfermentative previously identified as constitutive of the crypt-specific core microbiota in murine colonic samples are similarly prevalent in human colonic crypts in combination with other anaerobic taxa. We also show that bacterial signatures characterizing the crypts of colonic tumors vary depending whether right-side or left-side tumors are analyzed.
我们之前在健康实验鼠和相关野生啮齿动物的结肠中鉴定出一种特定于隐窝的核心微生物群(CSCM)。在这里,我们确认 CSCM 也存在于人类结肠中,并且似乎在结肠癌期间发生改变。肠道微生物群被认为与结直肠癌(CRC)的发展有关。由于从 CRC 患者粪便样本中鉴定出的微生物群并不能直接反映与肿瘤组织本身相关的微生物群,因此我们试图对 58 名患者(肿瘤和正常同源组织)和 9 名结肠镜检查结果正常的对照者的隐窝及其相关的相邻黏膜表面的细菌群落进行特征描述。在这里,我们确认细菌定植于控制和 CRC 组织中的人类结肠隐窝,并且使用激光微切割组织和 16S rRNA 基因测序,我们进一步表明右和左隐窝和黏膜相关的细菌群落存在显著差异。除了 和 之外,与鼠类近端结肠隐窝一样,环境非发酵 也存在于人类结肠隐窝中。 和 在右侧肿瘤中更为丰富,而 在左侧肿瘤中更为普遍。更准确地说,在右结肠的癌性样本的隐窝中, 比相邻区域的非肿瘤性样本更丰富,但在左结肠样本中则不然。对这些细菌与隐窝上皮,特别是肠干细胞之间相互作用的进一步分析,将允许解析其可能的致癌潜力。由于构成人类结肠微生物群的细菌数量庞大,其组成性分类群的平衡改变(即,生态失调)高度怀疑与结直肠肿瘤发生有关。实际上,已经描述了与 CRC 相关的细菌特征。如果在粪便或与肿瘤组织中鉴定出细菌,这些特征可能会有所不同。在这里,我们表明在来自 CRC 患者和结肠镜检查结果正常的患者的组织中,细菌定植于人类结肠隐窝。在鼠类结肠样本中被鉴定为 CSCM 组成性的需氧非发酵 与其他厌氧分类群一样普遍存在于人类结肠隐窝中。我们还表明,分析右侧或左侧肿瘤时,表征结肠肿瘤隐窝的细菌特征会有所不同。